{"transactions":[{"id":3097404,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-29T19:53:48.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":9579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Stock Option was granted in lieu of 2020 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2020, September 30, 2020 and December 31, 2020."}],"balance_after":21517,"derivative":{"exercise_price":2.52,"expiration_date":"2030-06-25","underlying":"Common Stock, par value $0.01 per share","underlying_shares":9579},"source":{"system":"sec-edgar","filing":"0001104659-20-078207","document":"tm2023734d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000110465920078207/tm2023734d5_4.xml","form_type":"4"}},{"id":3097403,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-29T19:53:48.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":11938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 25, 2020, December 25, 2020, March 25, 2021, and June 25, 2021."}],"balance_after":11938,"derivative":{"exercise_price":2.52,"expiration_date":"2030-06-25","underlying":"Common Stock, par value $0.01 per share","underlying_shares":11938},"source":{"system":"sec-edgar","filing":"0001104659-20-078207","document":"tm2023734d5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000110465920078207/tm2023734d5_4.xml","form_type":"4"}},{"id":3400565,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-10-02T16:35:24.000Z","date":"2019-09-30","kind":"other","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2,"exercise_date":"2017-12-27","expiration_date":"2022-12-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-19-046964","document":"tv530558_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000114420419046964/tv530558_4.xml","form_type":"4"}},{"id":3400564,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-10-02T16:35:24.000Z","date":"2019-09-30","kind":"other","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These warrants were transferred to the Reporting Person by DST Capital LLC on the condition that the Reporting Person immediately exercise the Warrants for cash."}],"balance_after":25000,"derivative":{"exercise_price":2,"exercise_date":"2017-12-27","expiration_date":"2022-12-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-19-046964","document":"tv530558_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000114420419046964/tv530558_4.xml","form_type":"4"}},{"id":3400563,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T16:35:24.000Z","date":"2019-09-30","kind":"other","acquired":true,"shares":25000,"price":2,"value":50000.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001144204-19-046964","document":"tv530558_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000114420419046964/tv530558_4.xml","form_type":"4"}},{"id":3500104,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-05T16:32:39.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":8411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This Stock Option was granted in lieu of 2019 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2019, September 30, 2019, and December 31, 2019."}],"balance_after":18775,"derivative":{"exercise_price":2.9,"expiration_date":"2029-06-03","underlying":"Common Stock, par value $0.01 per share","underlying_shares":8411},"source":{"system":"sec-edgar","filing":"0001144204-19-029896","document":"tv523169_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000114420419029896/tv523169_form4.xml","form_type":"4"}},{"id":3500103,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-05T16:32:39.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":10364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 3, 2019, December 3, 2019, March 3, 2020, and June 3, 2020."}],"balance_after":10364,"derivative":{"exercise_price":2.9,"expiration_date":"2029-06-03","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10364},"source":{"system":"sec-edgar","filing":"0001144204-19-029896","document":"tv523169_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000114420419029896/tv523169_form4.xml","form_type":"4"}},{"id":3760633,"issuer":{"id":7501,"kind":"organization","name":"Harvard Apparatus Regenerative Technology, Inc.","symbol":"HRGN"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-16T17:13:49.000Z","date":"2018-11-13","kind":"grant","acquired":true,"shares":10897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option shares will vest in four equal installments on February 13, 2019, May 13, 2019, August 13, 2019, and November 13, 2019."}],"balance_after":10897,"derivative":{"exercise_price":2.75,"expiration_date":"2028-11-13","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10897},"source":{"system":"sec-edgar","filing":"0001144204-18-060553","document":"tv507511_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367556/000114420418060553/tv507511_form4.xml","form_type":"4"}},{"id":3843992,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Nonqualified Stock Option (right to buy)","published_at":"2018-08-15T16:16:02.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":170000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001209191-18-046773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046773/doc4.xml","form_type":"4"}},{"id":3843991,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-15T16:16:02.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unexercised Issuer stock options (whether vested or unvested) was cancelled in exchange for cash equal to the product of (i) the excess of the Offer Price over the exercise price of the option and (ii) shares issuable upon exercise of the outstanding stock options."}],"balance_after":0,"derivative":{"exercise_price":7.9,"expiration_date":"2025-02-09","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-046773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046773/doc4.xml","form_type":"4"}},{"id":3843990,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-15T16:16:02.000Z","date":"2018-08-14","kind":"disposition_to_issuer","acquired":false,"shares":30413,"price":11.5,"value":349749.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") among Catalent Pharma Solutions, Inc., Catalent Boston, Inc. and Juniper Pharmaceuticals Inc. (the \"Issuer\") dated as of July 2, 2018.  At the effective time of the merger (the \"Effective Time\") as contemplated in the Merger Agreement, each share of outstanding Issuer common stock (other than appraisal shares and certain other shares), and each outstanding and unexercised Issuer stock option (whether vested or unvested) and each outstanding unvested restricted stock unit, immediately prior to the Effective Time were cancelled in exchange for $11.50 per share, net in cash, without interest, less any applicable taxes and applicable exercise price for the stock option (the \"Offer Price\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 27,150 restricted stock units that did not vest prior to the Effective Time of the merger.  Pursuant to the Merger Agreement, at the Effective Time, each of the outstanding and unvested 27,150 restricted stock units was cancelled in exchange for the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-046773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118046773/doc4.xml","form_type":"4"}},{"id":4064334,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-13T16:13:17.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant."}],"balance_after":40000,"derivative":{"exercise_price":7.9,"expiration_date":"2028-02-09","underlying":"Common stock, $0.01 par value per share","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-009524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009524/doc4.xml","form_type":"4"}},{"id":4064333,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-13T16:13:17.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":18400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Restricted Stock Unit Award shall vest 25% on each anniversary of the date of grant over 4 years."}],"balance_after":21663,"source":{"system":"sec-edgar","filing":"0001209191-18-009524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009524/doc4.xml","form_type":"4"}},{"id":4069377,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-09T19:45:35.000Z","date":"2018-02-07","kind":"tax_withholding","acquired":false,"shares":1737,"price":8.4,"value":14590.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The total number of shares acquired is net of the number of shares withheld for the payment of taxes."}],"balance_after":3263,"source":{"system":"sec-edgar","filing":"0001209191-18-009018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009018/doc4.xml","form_type":"4"}},{"id":4069376,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-09T19:45:35.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of JNP common stock issued upon partial vesting of a restricted stock unit award that vests upon the compensation committee's certification of the achievement of certain performance/milestone goals."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-18-009018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919118009018/doc4.xml","form_type":"4"}},{"id":4500183,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":148197,"kind":"person","name":"Young Jeffrey E","position":1,"cik":"0001367556","reported_name":"Young Jeffrey E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Nonqualified Stock Option (right to buy)","published_at":"2017-01-05T16:09:40.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock option is an inducement grant made pursuant to NASDAQ Stock Market Rule 5635(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant."}],"balance_after":170000,"derivative":{"exercise_price":5.6,"expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001209191-17-001981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919117001981/doc4.xml","form_type":"4"}}]}